CoChat

Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis

Open access
Seksenyan, Akop, Ron‐Harel, Noga, Azoulay, David, Cahalon, Liora, Cardon, Michal, Rogeri, Patricia, Ko, Minhee K., Weil, Miguel, Bulvik, Shlomo, Rechavi, Gideon, Amariglio, Ninette, Konen, Eli, Koronyo‐Hamaoui, Maya, Somech, Raz, Schwartz, Michal · 2010 · Journal of Cellular and Molecular Medicine
Cited by 37

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating disease, characterized by extremely rapid loss of motor neurons. Our studies over the last decade have established CD4+ T cells as important players in central nervous system maintenance and repair. Those results, together with recent findings that CD4+ T cells play a protective role in mouse models of ALS, led us to the current hypothesis that in ALS, a rapid T‐cell malfunction may develop in parallel to the motor neuron dysfunction. Here, we tested this hypothesis by assessing thymic function, which serves as a measure of peripheral T‐cell availability, in an animal model of ALS (mSOD1 [superoxide dismutase] mice; G93A) and in human patients. We found a significant reduction in thymic progenitor‐cell content, and abnormal thymic histology in 3–4‐month‐old mSOD1 mice. In ALS patients, we found a decline in thymic output, manifested in the reduction in blood levels of T‐cell receptor rearrangement excision circles, a non‐invasive measure of thymic function, and demonstrated a restricted T‐cell repertoire. The morbidity of the peripheral immune cells was also manifested in the increase of pro‐apoptotic BAX/BCXL2 expression ratio in peripheral blood mononuclear cells (PBMCs) of these patients. In addition, gene expression screening in the same PBMCs, revealed in the ALS patients a reduction in key genes known to be associated with T‐cell activity, including: CD80, CD86, IFNG and IL18. In light of the reported beneficial role of T cells in animal models of ALS, the present observation of thymic dysfunction, both in human patients and in an animal model, might be a co‐pathological factor in ALS, regardless of the disease aetiology. These findings may lead to the development of novel therapeutic approaches directed at overcoming the thymic defect and T‐cell deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2009.00863.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 37

Metadata

Authors
Seksenyan, A., Ron‐Harel, N., Azoulay, D., Cahalon, L., Cardon, M., Rogeri, P., Ko, M. K., Weil, M., Bulvik, S., Rechavi, G., Amariglio, N., Konen, E., Koronyo‐Hamaoui, M., Somech, R., & Schwartz, M.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2009-07-24
Volume
14
Issue
10
Pages
2470-2482
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2100944105
Cited by
37
References
17
FWCI
1.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00863.x
The paper
Seksenyan, A., Ron‐Harel, N., Azoulay, D., Cahalon, L., Cardon, M., Rogeri, P., Ko, M. K., Weil, M., Bulvik, S., Rechavi, G., Amariglio, N., Konen, E., Koronyo‐Hamaoui, M., Somech, R., & Schwartz, M. (2010). Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00863.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.